chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began to get nauseated and dizzy about 30 min after receiving vaccine. Within the hour was too dizzy to drive, walk. Nausea mostly went away next day but vertigo has remained.
pt complains of a very painful arm which is hot, red and swollen - told to use cold compress, otc pain reliever, watch for worsening & report to MD
Information has been received from a physician concerning a male who on 28-JUN-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (Lot number, injection site and route not reported). On 06-AUG-2008, the patient went to the doctor's office with rash. According to the physician, the rash looked like varicella, or rash from vaccine or the vaccine didn't work. Unspecified medical attention was sought. Additional information has been requested.
Information has been received from a medical assistant referring to a 11 years old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 14-JUL-2017, the patient was vaccinated with the third dose of GARDASIL 9 (lot # N002720, expiration date 12-MAY-2019)  (dose, route of administration and anatomical location were not reported) for prophylaxis. The administered doses of vaccine was exposed to a temperature excursion between 46.8 degrees Fahrenheit (F) which lasted for a 18 hours and 59 degrees Fahrenheit (F) which lasted for 65 hours on 13-JUN-2017. There was 59F previous temperature excursion for 4 hours. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA005381: US-009507513-1707USA010591: US-009507513-1709USA012722: US-009507513-1709USA012723: US-009507513-1709USA012724: US-009507513-1709USA012725: US-009507513-1709USA012726: US-009507513-1709USA012727: US-009507513-1709USA012728: US-009507513-1709USA012730: US-009507513-1709USA012731: US-009507513-1709USA012732: US-009507513-1709USA012733: US-009507513-1709USA010537: US-009507513-1709USA012774: US-009507513-1709USA012777: US-009507513-1709USA012776:
Diarrhea x 7 days, Sore throat, congestion, heavy breathing, very tired
Site: Pain at Injection Site-Mild, Systemic: menstuation  prolong-Mild, Additional Details: pt had covid shot on 09/3/21 1;29pm first shot, next day on 09/4/21, start her period and never stop until 09/24/21, still got second dose on 09/24/21
Low grade fever approximately 24 hours, chills, body aches, headache with "brain fog" feeling, fatigue, and general malaise approximately 36 hours
COVID arm from both doses of the Moderna COVID-19; ever since 2nd vaccine, I haven't had a period; This spontaneous case was reported by a pharmacist and describes the occurrence of MENSTRUAL DISORDER (ever since 2nd vaccine, I haven't had a period   ) and VACCINATION COMPLICATION (COVID arm from both doses of the Moderna COVID-19) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MIRTAZAPINE (REMERON) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MENSTRUAL DISORDER (ever since 2nd vaccine, I haven't had a period   ). On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm from both doses of the Moderna COVID-19). At the time of the report, MENSTRUAL DISORDER (ever since 2nd vaccine, I haven't had a period   ) and VACCINATION COMPLICATION (COVID arm from both doses of the Moderna COVID-19) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-233523 (Patient Link).
Showed large red areas around the injection site/ Redness covered most of their upper arm from the elbow to shoulder; The red area was warmer to the touch than other areas of the skin; The red area was somewhat swollen; This spontaneous case was received on 16-Oct-2023 from other non-healthcare professional (reference number SEQW23-03428) and concerned a 3-year-old, male patient.  The patient's medical history and concomitant medications were not reported.  On 14-Oct-2023, the patient was vaccinated with Flucelvax Quadrivalent vaccine (influenza vaccine inact sag 4v;  anatomical location reported as 'arm', dose, and route of administration: not reported) as influenza immunization. The batch number was not reported.  On 15-Oct-2023, approximately 32 hours after receiving Flucelvax Quadrivalent vaccine, the patient experienced large red areas around the injection site. The redness covered most of his upper arm from the elbow to shoulder. The red area was warmer to the touch than other areas of the skin and were somewhat swollen.  The outcome of the events was not reported.  The reporter did not provide causality assessment.  The case was assessed as non-serious.  This case is linked with the case 202305219 (the same reporter).  Company comment: A 3-year-old patient was vaccinated with Flucelvax Quadrivalent vaccine. One day after receiving the suspect vaccine, the patient experienced erythema, skin warm and swelling. Causality is assessed as possibly related, due to plausible temporal relationship.; Sender's Comments: A 3-year-old patient was vaccinated with Flucelvax Quadrivalent vaccine. One day after receiving the suspect vaccine, the patient experienced erythema, skin warm and swelling. Causality is assessed as possibly related, due to plausible temporal relationship.
Swelling in the face; Rashes all over body; A spontaneous report was received from a healthcare professional concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swelling in the face and rashes all over his body.  The patient's medical history was not provided. No concomitant medications were reported.  On 04 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 07 Jan 2021, the patient was hospitalized due to swelling in the face and rashes all over his body. Treatment for the events included epinephrine.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome for the events, swelling in the face and rashes all over his body, was unknown.; Reporter's Comments: This case concerns a male patient (unknown age), who experienced events of swelling in the face and rashes all over his body.  The events occurred 4 days after the first and only dose of mRNA-1273 vaccine administration. Based on the current limited available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.
Narrative: Symptoms:  ErythemaMultiform & Edema at injection site Treatment:  ACETAMINOPHEN 650MG PO Q4H PRN MG PRN
Started early menstrual cycle after receiving vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of MENSTRUAL DISORDER (Started early menstrual cycle after receiving vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced MENSTRUAL DISORDER (Started early menstrual cycle after receiving vaccine). At the time of the report, MENSTRUAL DISORDER (Started early menstrual cycle after receiving vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication include birth control pills.  No treatment information provided.   Reporter did not allow further contact
Pt with bilateral lower leg maculopapular rash. Rash is not present elsewhere on body. Does not appear urticarial. Pt has never had this rash in the past. Mildly pruritic.
Tinnitus in the left ear started two days after the vaccine on April 12th. At the moment of this report, I have had constant tinnitus for 5 weeks. For treatment, I originally took homeopathic remedies and then switched to Sudafed for 10 days. While the condition has improved a bit, it's persisting. I have no history of tinnitus more than airplane ear/fullness when I feel tired or not hydrated enough.
Presenting symptom: dysartrhia and aphasia without evidence of underlying cause.  Patient has been having continued TIA type symptoms with chest pressure & pain.  Difficulty in walking, speaking, arm drift.  This has happened on 3 different hospital occasions.  Negative cardiac workup, negative brain scan. Presumptive dx TIA. No prior history, no family history, no underlying medical reason.
Immediately after the vaccine was injected I felt a sensation down my arm and into my hand.  It felt strange and tingly all the way down.  This feeling lasted for several days.  The feeling has subsided a little but I still have a weird sensation in my hand, mostly on the outer side, and in my ring and pinky fingers.  I looked online and it seems consistent with the injection hitting a nerve in my arm.  My upper arm around the injection site is still sore 2 1/2 weeks after the vaccination and I don't have full range of motion in my left arm without some pain.
That night fever 102 after medication continued 101. Severe chills, severe dizziness and lightheaded. Nausea, severe ache in neck and lower back. Migraine. 1 week later, intermittent fatigue and weakness. Fever. Inability to perform at normal activity level. Unable to workout due to high heart rate (at minimal activity 180), along with dizziness and weakness. I see bright splotches of light when I try.
Nausea, unusually tired and soreness the first evening. Second day noticed hives in my hands both front and back along with a splitting headache for over 8 hours followed with nausea. The third day experienced further rash/hives and is current.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 81-year-old male patient who received Shingrix for prophylaxis. Concurrent medical conditions included dribbling of urine (was previously under control with medication). On 10th December 2018, the patient received the 1st dose of Shingrix (intramuscular). On 10th December 2018, less than a day after receiving Shingrix, the patient experienced injection site pain. On 12th December 2018, the patient experienced headache, tremor, shivering, unsteadiness, tiredness, upset stomach, dribbling of urine and condition aggravated. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the headache, tremor and shivering were recovering/resolving and the outcome of the unsteadiness, tiredness, upset stomach, dribbling of urine and condition aggravated were unknown. It was unknown if the reporter considered the injection site pain, headache, tremor, shivering, unsteadiness, tiredness, upset stomach, dribbling of urine and condition aggravated to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix in the left deltoid. Batch number was not provided.
Initial report received on 06.Oct.2009 from a pharmacist, who is the father of the patient. This 31-year old healthy female patient with no known underlying medical conditions took three capsules of VIVOTIF (Batch no.: unknown). About 24 hours after taking the third capsule she noted bloody stool. She went to visit her physician, no information received on findings or advises yet. The patient had HEP A and B vaccinations 2 weeks prior to starting oral vaccination with VIVOTIF. Concomitant medication was TRAMADOL because of an accident she had several weeks ago. Follow-up information has been requested on 07.Oct.2009.
Information has been received concerning an 8 year old white male allergic to amoxicillin and cefprozil (CEFZIL) who on 14-JUN-1999 was vaccinated with a subcutaneous dose of varicella virus vaccine live (Oka/Merck) (Lot #629259/0307J) in the right arm. Concomitant vaccines administered on the same day included a subcutaneous dose of measles-mumps-rubella vaccine (M-M-R II) (630261/0133J) administered in the left arm. The patient had no illness at the time of vaccination. On 10-MAY-2007 the patient developed a fine papular rash, some with papular centers and pustules, approximately 4-5 on the abdomen. Subsequently, the patient recovered. Additional information has been requested.
Pain near injection site on date of injection. Following day felt ill, achy, upset stomach and no appetite. On Tuesday developed rash below injection site, swollen and inflamed. Personally talked to pharmacist around noon. Around 8 PM went to Hospital ER.
PAIN ON RIGHT SIDE OF BODY/HURT ALL OVER; FELT SICK; SEVERE HEADACHE; This spontaneous report received from a patient concerned a 56 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced pain on right side of body/hurt all over. On 08-APR-2021, the subject experienced felt sick. On 08-APR-2021, the subject experienced severe headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain on right side of body/hurt all over, and felt sick on 18-APR-2021, and was recovering from severe headache. This report was non-serious.
Developed rash on right hand, which spread to other areas on my body (left hand, wrists, neck, back).
The first day: I had symptoms of fatigue, mild headache, dizziness and buzzing in my ears, could not get out of bed, in the afternoon I had fever (99F), my arm was burning and it hurt. I called the Dr. and she told me the symptoms the vaccine causes (headache, burning). She told me to wait a week and if it continued to go see a doctor. I took anti-allergy medicine and it helped me. I am taking azelastine (nasal allergy) and it has helped me. 2nd day: Rapid heart palpitations (heart pounding). 3rd day: Palpitations and shortness of breath when changing positions. I also have a pain above my hip on the right side.
This spontaneous report as received from a pharmacy technician concerning a currently 5 years old child. Gender was not reported. Medical history and concurrent conditions were not reported. On 02-APR-2014, the patient was vaccinated with VARIVAX lot #J009165; expiration date: 24-JUL-2015 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Vaccine was given 1 day past its beyond use date. Moderna was contacted and stated the vaccine "maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."
Severe muscle spasms on the left side, arm, thigh and calf the next day; Severe SI joint, hip joint and knee joint for 2 days after the vaccine.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Aug2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not take any concomitant medications. On 08Aug2021, the patient experienced severe muscle spasms on the left side, arm, thigh and calf the next day and severe sacroiliac (SI) joint, hip joint and knee joint for 2 days after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe muscle spasms on the left side, arm, thigh and calf was resolved with sequelae on an unknown date in Aug2021; while of the event severe SI joint, hip joint and knee joint was resolved with sequelae on 10 Aug2021, after the duration of 2 days.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Nov2021 as dose 3 (booster), single (Lot number: 077C21B) at the age of 26 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: WELLBUTRIN; HYDROXYZINE; OMEPRAZOLE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Oct2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient has received antiviral drug for the treatment of COVID 19 from 27Sep2022 to 02Oct2022. 6 days after treatment ended on 08Oct2022 again tested positive for COVID-19. Runny nose and cough was rebounded breakthrough as a symptoms, patient was not recovered and no treatment received. Patient had no seriousness criteria such as death, disabling/Incapacitating, life threatening, congenital anomaly/birth defect.
Initial report received from a health care professional via Novartis employee on 10 May 2010: This patient was vaccinated with MENVEO (batch no: CWY lot: 091991, A lot: 100004), (dose: unknown) intramuscularly unknown date. While withdrawing reconstituted vaccine from a vial, the vaccine ran down the nurse arm. The outcome of the event was not reported.
Pt was sitting on the exam table, Initial BP taken 129/86 left arm sitting, pt did express that she was very anxious. This nurse reviewed possible side effects of the vaccines that are going to be administered, Pt and mother both verbalized understanding of education provided. MCV4 administered in the left arm, pt tolerated procedure. HPV given in left arm, pt appeared to be holding her breath, pt appeared to be having the beginnings of pre-syncopal episodes. This nurse placed her hands on the pt back and arm to provided support at 419 pm pt appears to have fainted, this nurse called out for help Dr and NP, and multiple nurses responded.  pt was then laid down on the exam table. Pt did not fall or sustained any injuries. pt became alert at 420,  startled awake and trying to sit up, this nurse reassured the pt and had her lay down on the exam table. 421 PM B/P L arm supine 157/54 HR 90, 424 PM B/P L arm supine 119/78 HR 88, 428 PM B/P L arm supine 117/74 HR 82, 436 PM B/P L arm supine 122/77 HR 81,  442 PM B/P L arm sitting 117/76 HR 78 , 448 PM B/P L arm standing 119/80 HR 80. Once pt was alert she complained of feeling funny, and nausea. Pt attempted to sit up at 430 she drank a few sips of water and stated that she didn't feel good and laid back down. At 440 pt stated that she felt better and wanted to sit up, Pt sat on the side of the exam table and drank a glass of water. Pt stated at this time she is feeling better. At 448 pt was able to stand unassisted, with no complaints of dizziness, blurred vision, nausea, or SOB. Reviewed with the pt and mother on syncope episodes and future medical procedures/vaccines both verbalized understanding. Dr.  escorted pt to their car, pt was able to ambulate unassisted to the car.  Follow up with pts mother on may 10 2023 , no complaints states" she is doing fine.", pt went to school that day.
Information has been received from a 70 year old female with hypothyroid and acid reflux and a history of drug reaction to unspecified flu shot who on 15-JUL-2008 was vaccinated with a dose of ZOSTAVAX. Concomitant therapy included SYNTHROID, NEXIUM and ACTONEL. On 16-JUL-2008, the patient developed soreness and lump on the injection site. On 21-JUL-2008, the patient
Large swelling at the left deltoid where the shot was given, size of half of a fist, hot, hard, and itchy.
On 02/03/2021, I felt congestion, coughing up phlegm, voice was low, I couldn't bend over. Went to the doctor on 02/05/2021 diagnosed with bronchitis. Only lasted about 3 days.
Vomiting Diarrhea  Headache for days on right side where I had bells palsy
No know adverse event per mom. Follow-up: To date, there has been no adverse event.
Immunization given 3/21/2007.  Pt came in yesterday 2/12/2008 and stated that since immunization she has had nasal congestion with constant runny nose and loss of taste.  She has taken antihistamines without success.  She was sent to see our occupational health physician.
Rush (4"x2") on the place of the injection 9 days after the injection (January 31st) that lasted 3 full days.
First day -- fever, body ache, headache. 2nd day -- Chest pain, trouble breathing, fast heart rate and dizziness. -- diagnosed with pericarditis after ER visit.
pt recv vax 7OCT96 1030AM & returned to daycare later mom notified that temp had gone up to 102;pt was having shaking spell & was blue;pt taken to ER t013;given Ibuprofen & released home;pt exp staring into space & no response;dx rxn to vax
fever 105 for 4 days-rash all over body, dehydration, low platelet count;low RBC count;
Patient came back to the front of the pharmacy  with symptoms of itchiness and numbness around the mouth area after 30 minutes of receiving her vaccination. Patient was observed for about another 45 minutes after receiving 2 tablets of Benadryl and symptoms subsided. Patient was able to go back home with her spouse after confirming her improvement.
On 11/11/99, the pt experienced a low grade fever that broke on 11/13/99. On 11/13/99, the pt also developed a rash on her torso that was lacey initially. By 11/14/99, the rash was spotty over her torso. The rash mostly went away by 11/5/99. On 11/16/99, the pt experienced swelling of her top lip with no evidence of trauma. The pt was reportedly cranky. On 11/17/99, it was reported that the pt cried when her mother accidentally touched her neck. The pt's mother found a hard knot directly under the jaw bone about even between her ear and chin. It was described as bigger than a grape and about the size of a gumball. The pt was taken immediately to her physician. The pt was examined and found to have a fever of 99 degrees. No other symptoms were found. The pt is being treated with Benadryl and Tylenol.